Recent Advances
Authors:
- Richard KirschRKRichard Kirsch
- Pauline de la M. HallPHPauline de la M. Hall
- Jacob GeorgeJGJacob George
- Arthur J. McculloughAMArthur J. Mccullough
- Geoffrey C. FarrellGFGeoffrey C. Farrell
- 25 October 2004
- book chapter
- Published by Wiley
- p. 289-302
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- The effect of donor weight reduction on hepatic steatosis for living donor liver transplantationLiver Transplantation, 2004
- Nonalcoholic fatty liver disease: is all the fat bad?Internal Medicine Journal, 2004
- Acarbose attenuates experimental non-alcoholic steatohepatitisBiochemical and Biophysical Research Communications, 2004
- Negative trials in nonalcoholic steatohepatitis: Why they happen and what they teach usHepatology, 2004
- Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient l-amino acid-defined dietBiochemical and Biophysical Research Communications, 2004
- Obesity and diabetes as a risk factor for hepatocellular carcinomaLiver Transplantation, 2004
- CYP2E1: from ASH to NASHHepatology Research, 2004
- Polyunsaturated Fatty Acids Ameliorate Hepatic Steatosis in Obese Mice by Srebp–1 SuppressionHepatology, 2003
- Oxidative stress, KLF6 and transforming growth factor-β up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in ratsJournal of Hepatology, 2003
- Improved Nonalcoholic Steatohepatitis After 48 Weeks of Treatment With the Ppar–γ Ligand RosiglitazoneHepatology, 2003